A global perspective on vasoactive agents in shock

Djillali Annane, Lamia Ouanes-Besbes, Daniel de Backer, Bin DU, Anthony C Gordon, Glenn Hernández, Keith M Olsen, Tiffany M Osborn, Sandra Peake, James A Russell, Sergio Zanotti Cavazzoni, Djillali Annane, Lamia Ouanes-Besbes, Daniel de Backer, Bin DU, Anthony C Gordon, Glenn Hernández, Keith M Olsen, Tiffany M Osborn, Sandra Peake, James A Russell, Sergio Zanotti Cavazzoni

Abstract

Purpose: We set out to summarize the current knowledge on vasoactive drugs and their use in the management of shock to inform physicians' practices.

Methods: This is a narrative review by a multidisciplinary, multinational-from six continents-panel of experts including physicians, a pharmacist, trialists, and scientists.

Results and conclusions: Vasoactive drugs are an essential part of shock management. Catecholamines are the most commonly used vasoactive agents in the intensive care unit, and among them norepinephrine is the first-line therapy in most clinical conditions. Inotropes are indicated when myocardial function is depressed and dobutamine remains the first-line therapy. Vasoactive drugs have a narrow therapeutic spectrum and expose the patients to potentially lethal complications. Thus, these agents require precise therapeutic targets, close monitoring with titration to the minimal efficacious dose and should be weaned as promptly as possible. Moreover, the use of vasoactive drugs in shock requires an individualized approach. Vasopressin and possibly angiotensin II may be useful owing to their norepinephrine-sparing effects.

Keywords: Adrenergic agonists; Cardiovascular system; Clinical trials; Practice guidelines; Shock.

References

    1. Crit Care. 2009;13(5):230
    1. Shock. 2008 Apr;29(4):446-51
    1. Crit Care Med. 2016 Jan;44(1):23-31
    1. N Engl J Med. 2008 Feb 28;358(9):877-87
    1. Crit Care Med. 2012 Dec;40(12):3146-53
    1. Lancet. 2007 Aug 25;370(9588):676-84
    1. Crit Care Clin. 2014 Jul;30(3):391-412
    1. J Trauma. 2008 Jan;64(1):9-14
    1. N Engl J Med. 2010 Mar 4;362(9):779-89
    1. Crit Care Med. 2009 Jun;37(6):1961-6
    1. Shock. 2013 Jun;39(6):533-8
    1. Am J Cardiol. 2004 May 15;93(10):1309-12
    1. Crit Care. 2016 Apr 12;20:100
    1. Ann Am Thorac Soc. 2018 Feb;15(2):250-257
    1. J Pharmacol Exp Ther. 1957 Aug;120(4):512-27
    1. PLoS One. 2013 Nov 06;8(11):e80190
    1. Shock. 2018 Feb 7;:null
    1. Eur Heart J. 2016 Jul 14;37(27):2129-2200
    1. Intensive Care Med. 2014 Dec;40(12):1795-815
    1. Crit Care. 2011;15(5):R222
    1. Crit Care. 2008;12(6):R155
    1. Hypertension. 1997 Nov;30(5):1112-20
    1. JAMA. 1994 Nov 2;272(17):1354-7
    1. J Trauma. 2011 Sep;71(3):565-70; discussion 570-2
    1. J Appl Physiol (1985). 2017 Jun 1;122(6):1406-1417
    1. Intensive Care Med. 2003 Jun;29(6):1020-1023
    1. Intensive Care Med. 1995 Mar;21(3):218-25
    1. N Engl J Med. 2014 Apr 24;370(17):1583-93
    1. Crit Care. 2010;14(6):R232
    1. J Clin Pharmacol. 1986 Mar;26(S1):A3-A14
    1. Crit Care Med. 2006 Feb;34(2):403-8
    1. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1219-25
    1. Clin Sci (Lond). 2016 Sep 2;:
    1. Crit Care Med. 2009 Mar;37(3):811-8
    1. Crit Care Med. 2011 Apr;39(4):689-94
    1. Lancet. 2005 Jan 1-7;365(9453):63-78
    1. Am J Respir Crit Care Med. 2010 Sep 15;182(6):752-61
    1. Crit Care Clin. 2009 Oct;25(4):781-802, ix
    1. Circulation. 2002 Jul 30;106(5):550-5
    1. Am J Respir Crit Care Med. 2013 Aug 1;188(3):356-64
    1. Intensive Care Med. 2010 Nov;36(11):1882-9
    1. Crit Care Med. 2014 Jul;42(7):e525-e533
    1. Acta Anaesthesiol Scand. 2009 May;53(5):581-8
    1. Ann Thorac Surg. 2017 Jul;104(1):36-41
    1. J Trauma. 1999 Oct;47(4):699-703; discussion 703-5
    1. Best Pract Res Clin Anaesthesiol. 2008 Jun;22(2):351-8
    1. N Engl J Med. 2018 Jan 25;378(4):370-379
    1. Emerg Med Clin North Am. 2018 Feb;36(1):85-106
    1. Crit Care Med. 1997 Aug;25(8):1279-82
    1. JAMA. 2013 Oct 23;310(16):1683-91
    1. Crit Care Med. 2005 Apr;33(4):780-6
    1. Regul Pept. 2000 Dec 22;96(1-2):23-9
    1. J Innate Immun. 2010;2(5):446-60
    1. Acta Anaesthesiol Scand. 2005 Oct;49(9):1387-90
    1. Cochrane Database Syst Rev. 2018 Jan 29;1:CD009669
    1. N Engl J Med. 1994 Jun 16;330(24):1717-22
    1. Crit Care Med. 2018 Jan;46(1):e17-e25
    1. Crit Care Med. 2012 Oct;40(10):2821-7
    1. Anesthesiology. 2017 Jan;126(1):85-93
    1. Crit Care. 2017 Aug 15;21(1):213
    1. Intensive Care Med. 2013 Aug;39(8):1435-43
    1. JAMA. 2016 Aug 2;316(5):509-18
    1. JAMA. 2017 Apr 11;317(14 ):1433-1442
    1. Crit Care. 2011;15(5):R217
    1. Am Heart J. 2007 Jan;153(1):98-104
    1. Am J Respir Crit Care Med. 2008 Jul 1;178(1):20-5
    1. Am Heart J. 2003 Feb;145(2):324-9
    1. Best Pract Res Clin Anaesthesiol. 2008 Jun;22(2):265-73
    1. Crit Care Med. 2016 Jan;44(1):234-6
    1. N Engl J Med. 2016 Oct 5;375(17 ):1638-1648
    1. Crit Care Med. 2013 Jan;41(1):143-50
    1. Crit Care Med. 2008 Jun;36(6):1701-6
    1. J Clin Invest. 1996 Apr 15;97(8):1916-23
    1. Intensive Care Med. 2010 Dec;36(12):2004-18
    1. Cochrane Database Syst Rev. 2016 Feb 15;2:CD003709
    1. BMJ Open. 2017 Nov 17;7(11):e017559
    1. N Engl J Med. 2013 Oct 31;369(18):1726-34
    1. J Crit Care. 2012 Dec;27(6):630-8
    1. Crit Care Med. 2011 Mar;39(3):450-5
    1. Crit Care Med. 2000 Aug;28(8):2729-32
    1. Anesthesiology. 2018 Jan;128(1):228
    1. Circulation. 2017 Oct 17;136(16):e232-e268
    1. J Intensive Care Med. 2017 Jan 1;:885066617716396
    1. Shock. 2014 Apr;41(4):269-74
    1. Shock. 2007 Dec;28(6):644-649
    1. Crit Care Med. 2003 Jun;31(6):1659-67
    1. J Infect. 2016 May;72 (5):525-36
    1. J Crit Care. 2017 Feb;37:91-98
    1. J Clin Anesth. 2017 Feb;37:43-48
    1. J Intensive Care Med. 2017 Jan 1;:885066617714209
    1. Crit Care Med. 1996 Sep;24(9):1580-90
    1. Clin Pharmacol Ther. 2000 Aug;68(2):143-50
    1. J Surg Res. 2014 May 15;188(2):503-9
    1. Intensive Care Med. 2007 Mar;33(3):485-94
    1. Chest. 2003 Dec;124(6):2256-60
    1. Best Pract Res Clin Anaesthesiol. 2016 Dec;30(4):479-489
    1. Int J Cardiol. 2016 Nov 1;222:303-312
    1. Crit Care. 2009;13(3):R92
    1. Anesthesiology. 2002 Mar;96(3):576-82
    1. J Cardiovasc Pharmacol Ther. 2017 Nov;22(6):552-563
    1. Baillieres Clin Endocrinol Metab. 1993 Apr;7(2):393-413
    1. Circulation. 1997 Mar 4;95(5):1122-5
    1. World J Surg. 2011 Feb;35(2):430-9
    1. Intensive Care Med. 2008 Dec;34(12):2226-34
    1. N Engl J Med. 2017 Aug 3;377(5):419-430
    1. JAMA. 2010 Feb 24;303(8):739-46
    1. Am J Emerg Med. 2012 Sep;30(7):1176-82
    1. J Vasc Res. 1995 Mar-Apr;32(2):100-5
    1. Crit Care. 2008;12(6):R143
    1. Intensive Care Med. 2011 Jun;37(6):963-9
    1. Intensive Care Med. 2001 Aug;27(8):1416-21
    1. J Exp Med. 1940 Jan 1;71(1):29-42
    1. Intensive Care Med. 2017 Mar;43(3):304-377
    1. Intensive Care Med. 2016 Sep;42(9):1350-9

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere